Catalyst Pharmaceuticals, Inc.
CPRXDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 395 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Catalyst Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Catalyst Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Elsbernd Brian | Chief Legal Officer | 0 | Jul 17, 2026 | 5 |
| Curran Daniel J. | Director | – | Jul 17, 2026 | 2 |
| Tierney David S | Director | 0 | Jul 17, 2026 | 4 |
| Miller Steve | Chief Op. & Scientific Officer | 0 | Jul 17, 2026 | 4 |
| Thompson Tamar | Director | 0 | Jul 17, 2026 | 3 |
| Russo Gregg | Chief HR Officer | 0 | Jul 17, 2026 | 3 |
| McEnany Patrick J | Director, Other: Chairman of Board of Directors | 0 | Jul 17, 2026 | 5 |
| Denkhaus Donald A | Director | 0 | Jul 17, 2026 | 4 |
| Del Carmen Jeffrey | Chief Commercial Officer | 0 | Jul 17, 2026 | 5 |
| Sundaram Preethi | Chief Strategy Officer | 0 | Jul 17, 2026 | 4 |
| Daly Richard J | President and CEO | 0 | Jul 17, 2026 | 4 |
| Andrews William T. | Chief Medical Officer | 0 | Jul 17, 2026 | 3 |
| Harper Molly | Director | 0 | Jul 17, 2026 | 5 |
| Kalb Michael Wayne | Chief Financial Officer | 0 | Jul 17, 2026 | 3 |
| Ingenito Gary | Chief Med. & Reg. Officer | 68,873 | May 15, 2025 | 0 |
| O'Keeffe Charles B | Director | 732,470 | Feb 19, 2025 | 0 |
| Grande Alicia | VP, Treasurer and CFO | 55,813 | Dec 29, 2023 | 0 |
| Coelho Philip H | Director | 204,887 | May 5, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 (view filing) | Nov 15 | 2 days | Grande AliciaVP, Treasurer and CFO | SSaleCommon Stock, par value $0.001 per share | −60.0K | $15.77 | −$946.2K | −28.9%147.4K after | |
| Nov 15, 2022 (view filing) | Nov 11 | 4 days | Sundaram PreethiChief Strategy Officer | SSaleCommon stock, par value $0.001 per share | −56.8K | $16.38 | −$929.9K | −100.0%0 after | 2 lots |
| Nov 15, 2022 (view filing) | Nov 11 | 4 days | Elsbernd BrianChief Compliance/Legal Officer | SSaleCommon stock, par value $0.001 per share | −14.7K | $16.24 | −$238.2K | −56.9%11.1K after | |
| Nov 15, 2022 (view filing) | Nov 11 | 4 days | Denkhaus Donald ADirector | SSaleCommon stock, par value $0.001 per share | −20.0K | $16.59 | −$331.8K | −6.7%277.7K after | |
| Nov 15, 2022 (view filing) | Nov 11 | 4 days | Del Carmen JeffreyChief Commercial Officer | SSaleCommon stock, par value $0.001 per share | −139.0K | $16.12 | −$2.24M | −100.0%0 after | 2 lots |
| Sep 26, 2022 (view filing) | Sep 23 | 3 days | Grande AliciaVP, Treasurer and CFO | SSaleCommon Stock, par value $0.001 per share | −60.0K | $11.90 | −$714.0K | −22.4%207.4K after | |
| Sep 20, 2022 (view filing) | Sep 16 | 4 days | Grande AliciaVP, Treasurer and CFO | SSaleCommon Stock, par value $0.001 per share | −90.0K | $13.50 | −$1.22M | −25.2%267.4K after | |
| Sep 16, 2022 (view filing) | Sep 15 | 1 day | Sundaram PreethiChief Strategy Officer | SSaleCommon stock, par value $0.001 per share | −18.2K | $14.49 | −$263.9K | −100.0%0 after | |
| Sep 16, 2022 (view filing) | Sep 14 | 2 days | Ingenito GaryChief Medical & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −143.0K | $15.67 | −$2.24M | −86.6%22.1K after | 2 lots |
| Sep 16, 2022 (view filing) | Sep 14 | 2 days | Grande AliciaVP, Treasurer and CFO | SSaleCommon Stock, par value $0.001 per share | −50.0K | $15.57 | −$778.5K | −12.3%357.4K after | |
| Sep 15, 2022 (view filing) | Sep 14 | 1 day | Denkhaus Donald ADirector | SSaleCommon stock, par value $0.001 per share | −20.0K | $15.34 | −$306.8K | −6.3%297.7K after | |
| Sep 15, 2022 (view filing) | Sep 13-14 | 2 days | McEnany Patrick JPresident and CEO | SSaleCommon stock, par value $0.001 per share | −1.03M | $15.40 | −$15.8M | −20.8%3.90M after | 2 lots |
| Sep 15, 2022 (view filing) | Sep 13 | 2 days | Miller SteveChief Operating Officer | SSaleCommon stock, par value $0.001 per share | −107.9K | $16.91 | −$1.82M | −14.2%653.8K after | 3 lots |
| Sep 15, 2022 (view filing) | Sep 13-14 | 2 days | Coelho Philip HDirector | SSaleCommon stock, par value $0.001 per share | −30.0K | $15.73 | −$472.0K | −10.7%249.6K after | 2 lots |
| Aug 30, 2022 (view filing) | Aug 26-29 | 4 days | Grande AliciaVP, Treasurer and CFO | SSaleCommon Stock, par value $0.001 per share | −68.1K | $14.23 | −$969.3K | −14.3%407.4K after | 4 lots |
| Aug 23, 2022 (view filing) | Aug 22 | 1 day | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −20.0K | $14.16 | −$283.2K | −6.1%308.2K after | |
| Aug 22, 2022 (view filing) | Aug 19 | 3 days | Del Carmen JeffreyChief Commercial Officer | SSaleCommon stock, par value $0.001 per share | +14.1K | $14.05 | +$198.7K | New position0 after | |
| Aug 19, 2022 (view filing) | Aug 18 | 1 day | Miller SteveChief Operating Officer | SSaleCommon stock, par value $0.001 per share | −118.6K | $13.56 | −$1.61M | −13.5%761.7K after | |
| Aug 19, 2022 (view filing) | Aug 18 | 1 day | Miller SteveChief Operating Officer | SSaleCommon Stock, par value $0.001 per share | −31.4K | $13.43 | −$422.0K | −4.0%761.7K after | |
| Aug 19, 2022 (view filing) | Aug 18-19 | 1 day | McEnany Patrick JPresident and CEO | SSaleCommon stock, par value $0.001 per share | −300.0K | $14.01 | −$4.20M | −5.7%4.93M after | 5 lots |
| Aug 19, 2022 (view filing) | Aug 17 | 2 days | Grande AliciaVP, Treasurer and CFO | SSaleCommon stock, par value $0.001 per share | −130.7K | $13.85 | −$1.81M | −21.6%475.5K after | 2 lots |
| Aug 19, 2022 (view filing) | Aug 18 | 1 day | Grande AliciaVP, Treasurer and CFO | SSaleCommon Stock, par value $0.001 per share | −19.3K | $13.70 | −$263.8K | −3.9%475.5K after | |
| Jun 23, 2022 (view filing) | Jun 21-22 | 2 days | Ingenito GaryChief Medical & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −150.0K | $6.60 | −$990.1K | −87.2%22.1K after | 2 lots |
| May 24, 2022 (view filing) | May 20 | 4 days | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −20.0K | – | – | −6.1%308.2K after | |
| Dec 8, 2021 (view filing) | Dec 7 | 1 day | Ingenito GaryChief Medical Officer | SSaleCommon stock, par value $0.001 per share | −3.61K | $6.99 | −$25.2K | −14.1%22.1K after | |
| Aug 26, 2021 (view filing) | Aug 25 | 1 day | Miller SteveChief Operating Officer | SSaleCommon stock, par value $0.001 per share | −80.0K | $5.56 | −$444.8K | −9.7%741.7K after | |
| Aug 26, 2021 (view filing) | Aug 24-26 | 2 days | Coelho Philip HDirector | SSaleCommon stock, par value $0.001 per share | −28.5K | $5.53 | −$157.8K | −10.7%238.2K after | 4 lots |
| Aug 24, 2021 (view filing) | Aug 20-23 | 4 days | McEnany Patrick JPresident and CEO | SSaleCommon stock, par value $0.001 per share | −136.8K | $5.59 | −$764.1K | −2.7%4.91M after | 2 lots |
| Aug 19, 2021 (view filing) | Aug 17-18 | 2 days | Grande AliciaVP, Treasurer and CFO | SSaleCommon stock, par value $0.001 per share | −113.0K | $5.67 | −$640.8K | −19.6%464.4K after | 2 lots |
| Aug 17, 2021 (view filing) | Aug 13 | 4 days | McEnany Patrick JPresident and CEO | SSaleCommon stock, par value $0.001 per share | −62.7K | $6.12 | −$383.8K | −1.3%4.85M after | 2 lots |
| Aug 17, 2021 (view filing) | Aug 13 | 4 days | Miller SteveChief Operating Officer | SSaleCommon stock, par value $0.001 per share | −41.0K | $6.09 | −$249.5K | −5.5%701.7K after | |
| Aug 17, 2021 (view filing) | Aug 13 | 4 days | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −50.0K | $6.08 | −$304.0K | −14.0%306.9K after |